ReadCrystal has established FBDD drug screening platform utilizing its biophysical
platform and X-ray protein crystallography technology.
2700+ “rule of three” compliant fragments
Diverse screening methods, including SPR, TRIC, AS-MS, NanoDSF, MST, ITC
Fragments with measurable KD and co-crystal results of target proteins with small molecule fragments are available
Provide protein-small molecule fragment co-crystal structures via X-ray crystallography techniques and soaking method
![](https://imgs-data-brwq.oss-cn-shanghai.aliyuncs.com/qyrj0115/uploads/20240204/2134a140454586afbcabfae344740db4.jpg)